Sale!

POLR3B Gene Leukodystrophy Hypomyelinating Type 8 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test is a specialized genetic analysis that detects mutations in the POLR3B gene responsible for hypomyelinating leukodystrophy type 8. This comprehensive test utilizes next-generation sequencing technology to identify specific genetic variants that disrupt normal myelin formation in the central nervous system. The test is crucial for individuals experiencing neurological symptoms such as developmental delays, motor coordination difficulties, and progressive neurological decline. By providing definitive genetic diagnosis, this test enables early intervention, personalized treatment planning, and accurate family risk assessment. The test costs $500 USD and provides results within 3-4 weeks, offering valuable insights for managing this rare neurological condition.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the POLR3B gene, which plays a critical role in RNA polymerase III function and is essential for proper myelin formation in the central nervous system. Hypomyelinating leukodystrophy type 8 is a rare inherited neurological disorder characterized by insufficient myelin production, leading to progressive neurological deterioration and significant impact on quality of life.

What This Test Measures and Detects

Our comprehensive NGS-based genetic analysis examines the entire coding region of the POLR3B gene to identify:

  • Point mutations and single nucleotide variants affecting gene function
  • Insertions and deletions that disrupt normal protein production
  • Splice site mutations that affect RNA processing
  • Compound heterozygous variants contributing to disease manifestation
  • Novel genetic alterations not previously documented

Who Should Consider This Test

This genetic test is recommended for individuals presenting with the following symptoms or clinical indications:

  • Progressive neurological decline in childhood or early adulthood
  • Developmental delays affecting motor skills and coordination
  • Abnormal white matter findings on brain MRI scans
  • Family history of leukodystrophy or similar neurological conditions
  • Unexplained ataxia, spasticity, or movement disorders
  • Delayed speech and language development
  • Progressive vision or hearing impairment
  • Intellectual disability with neurological involvement

Significant Benefits of Genetic Testing

Undergoing the POLR3B gene test provides numerous advantages for patients and families:

  • Definitive Diagnosis: Confirms or rules out hypomyelinating leukodystrophy type 8
  • Early Intervention: Enables timely treatment and management strategies
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Care: Guides targeted therapeutic approaches based on genetic findings
  • Prognostic Information: Helps predict disease progression and expected outcomes
  • Research Contribution: Advances scientific understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your POLR3B gene status:

  • Positive Result: Indicates the presence of pathogenic variants associated with hypomyelinating leukodystrophy type 8, requiring immediate consultation with a neurologist and genetic counselor
  • Negative Result: Suggests no detectable mutations in the POLR3B gene, though other genetic or non-genetic causes should still be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring further evaluation and possible family studies
  • Carrier Status: Determines if you carry a single copy of a mutated gene, important for family planning decisions

Test Pricing Information

Test Description Price (USD)
POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test – Discount Price $500
POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Availability

We proudly offer the POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our extensive network of certified collection centers ensures convenient access to this specialized genetic testing regardless of your location.

Take Control of Your Neurological Health

Don’t let uncertainty about neurological symptoms affect your quality of life. The POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of genetic specialists and neurologists are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic consultation and testing appointment. Early detection through genetic testing can make a significant difference in managing neurological conditions effectively.